Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Aug;74(3):400–405. doi: 10.1038/bjc.1996.372

Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.

E J Fadlon 1, R C Rees 1, C McIntyre 1, R M Sharrard 1, J Lawry 1, F C Hamdy 1
PMCID: PMC2074639  PMID: 8695355

Abstract

The presence of prostate-specific antigen (PSA)-positive cells has previously been demonstrated in the peripheral blood of prostate cancer patients by flow cytometry (FC), but the identity of these cells has not been established. In this study, the reverse transcriptase polymerase chain reaction (RT-PCR) was compared with analytical FC in an attempt to detect and characterise these cells. Peripheral blood was obtained from 12 patients with newly diagnosed and untreated prostate cancer and five controls. Nine of the 12 patients with prostate cancer (75%) had circulating PSA-positive cells as shown by FC. Only one of those patients (11.1%) was found to express PSA mRNA by RT-PCR. The absence of PSA mRNA in the majority of samples showing PSA-positive cells suggests that they do not represent haematogenous micrometastases. PSA-positive cells in the blood could represent monocytes that express PSA, either following binding/phagocytosis of free serum PSA or phagocytosis of tumour cells.

Full text

PDF
400

Images in this article

404Figure 2
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cama C., Olsson C. A., Raffo A. J., Perlman H., Buttyan R., O'Toole K., McMahon D., Benson M. C., Katz A. E. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J Urol. 1995 May;153(5):1373–1378. [PubMed] [Google Scholar]
  2. Chodak G. W., Thisted R. A., Gerber G. S., Johansson J. E., Adolfsson J., Jones G. W., Chisholm G. D., Moskovitz B., Livne P. M., Warner J. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994 Jan 27;330(4):242–248. doi: 10.1056/NEJM199401273300403. [DOI] [PubMed] [Google Scholar]
  3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  4. ENGELL H. C. Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl. 1955;201:1–70. [PubMed] [Google Scholar]
  5. Epstein J. I., Carmichael M. J., Pizov G., Walsh P. C. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol. 1993 Jul;150(1):135–141. doi: 10.1016/s0022-5347(17)35415-0. [DOI] [PubMed] [Google Scholar]
  6. Fidler I. J., Kripke M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977 Aug 26;197(4306):893–895. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]
  7. Fidler I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst. 1970 Oct;45(4):773–782. [PubMed] [Google Scholar]
  8. Fleming C., Wasson J. H., Albertsen P. C., Barry M. J., Wennberg J. E. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993 May 26;269(20):2650–2658. [PubMed] [Google Scholar]
  9. Hamdy F. C., Lawry J., Anderson J. B., Parsons M. A., Rees R. C., Williams J. L. Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol. 1992 Apr;69(4):392–396. doi: 10.1111/j.1464-410x.1992.tb15566.x. [DOI] [PubMed] [Google Scholar]
  10. Israeli R. S., Miller W. H., Jr, Su S. L., Powell C. T., Fair W. R., Samadi D. S., Huryk R. F., DeBlasio A., Edwards E. T., Wise G. J. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res. 1994 Dec 15;54(24):6306–6310. [PubMed] [Google Scholar]
  11. Israeli R. S., Miller W. H., Jr, Su S. L., Samadi D. S., Powell C. T., Heston W. D., Wise G. J., Fair W. R. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol. 1995 Mar;153(3 Pt 1):573–577. doi: 10.1016/s0022-5347(01)67651-1. [DOI] [PubMed] [Google Scholar]
  12. Katz A. E., Olsson C. A., Raffo A. J., Cama C., Perlman H., Seaman E., O'Toole K. M., McMahon D., Benson M. C., Buttyan R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology. 1994 Jun;43(6):765–775. doi: 10.1016/0090-4295(94)90132-5. [DOI] [PubMed] [Google Scholar]
  13. Lu-Yao G. L., McLerran D., Wasson J., Wennberg J. E. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA. 1993 May 26;269(20):2633–2636. doi: 10.1001/jama.269.20.2633. [DOI] [PubMed] [Google Scholar]
  14. Moreno J. G., Croce C. M., Fischer R., Monne M., Vihko P., Mulholland S. G., Gomella L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 1992 Nov 1;52(21):6110–6112. [PubMed] [Google Scholar]
  15. Poste G., Fidler I. J. The pathogenesis of cancer metastasis. Nature. 1980 Jan 10;283(5743):139–146. doi: 10.1038/283139a0. [DOI] [PubMed] [Google Scholar]
  16. Riegman P. H., Vlietstra R. J., van der Korput J. A., Romijn J. C., Trapman J. Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem Biophys Res Commun. 1989 Feb 28;159(1):95–102. doi: 10.1016/0006-291x(89)92409-1. [DOI] [PubMed] [Google Scholar]
  17. Schwartz R., Walk A., Toomes H., Schirrmacher V. Assay for the determination of human carcinoma cells in circulating blood. J Cancer Res Clin Oncol. 1985;109(2):122–129. doi: 10.1007/BF00391886. [DOI] [PubMed] [Google Scholar]
  18. Smith M. R., Biggar S., Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res. 1995 Jun 15;55(12):2640–2644. [PubMed] [Google Scholar]
  19. Warren E. R. MOUNTAIN ROAD CASUALTIES AMONG ANIMALS IN COLORADO. Science. 1936 Nov 27;84(2187):485–485. doi: 10.1126/science.84.2187.485. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES